Watch VideoGovernment health officials on Monday approved the first new drug for Alzheimer's disease in nearly 20 years, disregarding warnings from independent advisers that the much-debated treatment hasn't been shown to help slow the brain-destroying disease.
The Food and Drug Administration said it granted approval to the...
FDA Approves Highly Debated Alzheimer’s Drug
Newsy
0 shares
1 views
You might like
Related news coverage
The FDA is broken. It's controversial approval of an ineffective new Alzheimer's drug proves the agency puts profit over public health.
Business Insider
Because of how drug research is funded and the profit incentives of the FDA, most newly-approved drugs are ineffective and often..
-
The Upside for Biogen Is Absolutely Wild
Motley Fool
-
Why Biogen's FDA Approval Is Shocking
Motley Fool
-
Two House committees to investigate FDA's approval of Biogen's Alzheimer's drug
SeekingAlpha
-
Lilly to seek FDA approval for potential Alzheimer's drug
SeattlePI.com
Advertisement
More coverage
Eli Lilly jumps 10% after it says it will seek approval for its Alzheimer's drug following designation as a breakthrough therapy by the FDA
Business Insider
Goldman Sachs said Eli Lilly's decision to seek accelerated approval for donanemab was ahead of its expectations.
-
How the new Alzheimer’s disease drug could influence future research
Upworthy
-
Why Eli Lilly Stock Is Soaring Today
Motley Fool
-
Another Biogen Alzheimer's drug expedited by the FDA
bizjournals
-
Stocks end mixed but Nasdaq powers to another record close
Proactive Investors